cops a spanking, page-7

re: cops a spanking/refresher. I agree Spike , the market will have the final say , only thing is which market , and things are a long way from final , with the full results from the current trial still to come and psoriasis trials currently being unblinded .
I think you would be scratching to find any oncology drug developed here to have better results in their phase 2 trials that Coramsine has already achieved in their phase 1 . That result was achieved on a random mix of cancers . Once they concentrate on the types of cancer identified as the best targets , as in how a phase 2 is structured , watch them blow the others out of the water . And dosnt it give you a good feeling that what appears to be the best target is the biggest need today , NSCLC . This looks like a good chance for some accumulation .
Success in the multi billion psoriasis market will also be nice .
All in my honest opinion of course.
Cheers